Description

Currently, the only established therapeutic option for end-stage liver disease is orthotopic liver transplantation. However, the paucity of donor organs limits this option to only a few patients. From liver stem cells to advanced tissue bioengineering, this episode of EASL Studio discusses regenerative hepatology techniques as an alternative treatment for patients.

Faculty

  • Prof. Pedro Baptista (Moderator)
  • Prof. Tobias Cantz (Faculty)
  • Prof. Karen Piper Hanley (Faculty)
  • Prof. Frederic Lemaigre (Faculty)

Related episode:

ℹ️ Please click here to access the podcast version of this EASL Studio episode.